Infusive Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar General
DG
|
+$16.4M |
| 2 |
Electronic Arts
EA
|
+$11.7M |
| 3 |
PepsiCo
PEP
|
+$10.5M |
| 4 |
Lowe's Companies
LOW
|
+$10.4M |
| 5 |
Procter & Gamble
PG
|
+$10.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Estee Lauder
EL
|
+$8.86M |
| 2 |
lululemon athletica
LULU
|
+$6.92M |
| 3 |
Starbucks
SBUX
|
+$5.08M |
| 4 |
Ferrari
RACE
|
+$4.42M |
| 5 |
Constellation Brands
STZ
|
+$3.99M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 35.09% |
| 2 | Consumer Discretionary | 34.54% |
| 3 | Communication Services | 27% |
| 4 | Financials | 3.38% |
Similar funds
Infusive Asset Management's Q4 2023 Portfolio in Review
As of Q4 2023, Infusive Asset Management held 20 positions worth $221M, up 43% from $155M the previous quarter. Its ten largest holdings account for 70% of the portfolio.
Infusive Asset Management deployed $45.5M of net new capital in Q4 2023, opening 7 new positions and adding to 4 existing holdings. Its largest new stake was Dollar General: 134,910 shares worth $18.3M.
By sector, the portfolio is most concentrated in Consumer Staples at 35% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Starbucks, an estimated $5.08M trimmed.
- Infusive Asset Management's largest Q4 2023 buy was Dollar General: 134,910 shares worth $18.3M.
- Infusive Asset Management added most to PepsiCo in Q4 2023, an estimated $10.5M increase.
- Infusive Asset Management's biggest Q4 2023 reduction was Starbucks, cutting an estimated $5.08M.
- Infusive Asset Management fully exited Estee Lauder in Q4 2023, selling an estimated $8.86M.
- Infusive Asset Management's ten largest holdings make up 70% of its $221M portfolio in Q4 2023.
- Infusive Asset Management opened 7 new positions and closed 2 in Q4 2023.
- Infusive Asset Management's portfolio value rose 43% quarter-over-quarter to $221M.
Based on Infusive Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.